Acquired T790M Mutation in Patients Failing Treatment with First or Second-Generation EGFR-Tyrosine Kinase Inhibitors
Background: The majority of patients with epidermal growth factor receptor (EGFR)-mutant advanced non-small cell lung cancer (NSCLC) develop resistance to first- or second-generation EGFR-tyrosine kinase inhibitor (TKI) after a median treatment period of 12 months. This study aimed to determine the...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | E-Article |
| Language: | English |
| Published: |
Elsevier
2019
|
| Subjects: | |
| Online Access: | http://ir.unimas.my/id/eprint/28063/1/WLCC%202019%201.pdf http://ir.unimas.my/id/eprint/28063/ https://doi.org/10.1016/j.jtho.2019.08.2302 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|